These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 22215717

  • 1. Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling.
    Paulis L, Becker ST, Lucht K, Schwengel K, Slavic S, Kaschina E, Thöne-Reineke C, Dahlöf B, Baulmann J, Unger T, Steckelings UM.
    Hypertension; 2012 Feb; 59(2):485-92. PubMed ID: 22215717
    [Abstract] [Full Text] [Related]

  • 2. Allopurinol attenuates L-NAME induced cardiomyopathy comparable to blockade of angiotensin receptor.
    Kasal DA, Neves MF, Oigman W, Mandarim-de-Lacerda CA.
    Histol Histopathol; 2008 Oct; 23(10):1241-8. PubMed ID: 18712676
    [Abstract] [Full Text] [Related]

  • 3. Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in Nomega-nitro-L-arginine methyl ester-treated rats.
    Kanematsu Y, Tsuchiya K, Ohnishi H, Motobayashi Y, Izawa Y, Ishihara M, Ishizawa K, Abe S, Kawazoe K, Tamaki T.
    Hypertens Res; 2006 May; 29(5):369-74. PubMed ID: 16832158
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.
    Rehman A, Leibowitz A, Yamamoto N, Rautureau Y, Paradis P, Schiffrin EL.
    Hypertension; 2012 Feb; 59(2):291-9. PubMed ID: 22184324
    [Abstract] [Full Text] [Related]

  • 5. Augmentation of pulse wave velocity precedes vascular structural changes of the aorta in rats treated with N(omega)-nitro-L-arginine methyl ester.
    Kameyama H, Takeda K, Kusaba T, Narumiya H, Tanda S, Kuwahara N, Yamada K, Tamagaki K, Okigaki M, Hatta T, Sasaki S.
    Hypertens Res; 2005 May; 28(5):439-45. PubMed ID: 16156508
    [Abstract] [Full Text] [Related]

  • 6. Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats.
    Brouwers S, Smolders I, Wainford RD, Dupont AG.
    Clin Sci (Lond); 2015 Jul; 129(1):81-92. PubMed ID: 25655919
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H, Minamino T, Tsukamoto O, Kim J, Okada K, Myoishi M, Wakeno M, Takashima S, Mochizuki N, Kitakaze M.
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [Abstract] [Full Text] [Related]

  • 8. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
    Takemoto M, Egashira K, Tomita H, Usui M, Okamoto H, Kitabatake A, Shimokawa H, Sueishi K, Takeshita A.
    Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592
    [Abstract] [Full Text] [Related]

  • 9. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H, Nakagawa Y, Miki S, Shimizu T, Yoshimura A, Inoue R, Asayama J, Kobara M, Nakata T.
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [Abstract] [Full Text] [Related]

  • 10. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
    Bunbupha S, Prachaney P, Kukongviriyapan U, Kukongviriyapan V, Welbat JU, Pakdeechote P.
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
    Kusumoto K, Igata H, Ojima M, Tsuboi A, Imanishi M, Yamaguchi F, Sakamoto H, Kuroita T, Kawaguchi N, Nishigaki N, Nagaya H.
    Eur J Pharmacol; 2011 Nov 01; 669(1-3):84-93. PubMed ID: 21816148
    [Abstract] [Full Text] [Related]

  • 12. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S, Kitakaze M, Node K, Takashima S, Ogai A, Asanuma H, Sakata Y, Asakura M, Ogita H, Liao Y, Fukushima T, Yamada J, Minamino T, Kuzuya T, Hori M.
    Hypertension; 2001 Sep 01; 38(3):404-11. PubMed ID: 11566913
    [Abstract] [Full Text] [Related]

  • 13. In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester.
    Henrion D, Dowell FJ, Levy BI, Michel JB.
    Hypertension; 1996 Sep 01; 28(3):361-6. PubMed ID: 8794817
    [Abstract] [Full Text] [Related]

  • 14. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K, Sasamura H, Sakamaki Y, Itoh H, Saruta T.
    Hypertens Res; 2007 Jan 01; 30(1):63-75. PubMed ID: 17460373
    [Abstract] [Full Text] [Related]

  • 15. Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency.
    Nakmareong S, Kukongviriyapan U, Pakdeechote P, Kukongviriyapan V, Kongyingyoes B, Donpunha W, Prachaney P, Phisalaphong C.
    Hypertens Res; 2012 Apr 01; 35(4):418-25. PubMed ID: 22072109
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 17. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA, Paffaro VA, Pauli JR, da Silva GH, Saad MJ, Salgado I, da Cruz-Höfling MA, Hyslop S.
    Cell Tissue Res; 2007 Jul 15; 329(1):45-58. PubMed ID: 17436021
    [Abstract] [Full Text] [Related]

  • 18. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
    Priviero FB, Teixeira CE, Claudino MA, De Nucci G, Zanesco A, Antunes E.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):189-96. PubMed ID: 17610863
    [Abstract] [Full Text] [Related]

  • 19. Effects of olmesartan on arterial stiffness in rats with chronic renal failure.
    Chuang YC, Wu MS, Su YK, Fang KM.
    Cardiovasc Diabetol; 2012 Jun 13; 11():66. PubMed ID: 22694778
    [Abstract] [Full Text] [Related]

  • 20. Olmesartan improves endothelin-induced hypertension and oxidative stress in rats.
    Yao L, Kobori H, Rahman M, Seth DM, Shokoji T, Fan Y, Zhang GX, Kimura S, Abe Y, Nishiyama A.
    Hypertens Res; 2004 Jul 13; 27(7):493-500. PubMed ID: 15302986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.